COVID-19 Impact on Global Open-Angle Glaucoma Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: C147950FC99CEN
QYResearch

Abstracts

This report focuses on the global Open-Angle Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Open-Angle Glaucoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Aerie Pharmaceuticals Inc.
• Allergan Plc
• Bausch Health Companies, Inc.
• Novartis AG
• Pfizer Inc.
• ...

Market segment by Type, the product can be split into

• Prostaglandin Analogs (PGAs)
• Combination of PGAs
• Other

Market segment by Application, split into

• Hospital
• Clinic
• Research Institute
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Open-Angle Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Open-Angle Glaucoma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Open-Angle Glaucoma Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Prostaglandin Analogs (PGAs)
  1.4.3 Combination of PGAs
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Research Institute
  1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Open-Angle Glaucoma Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Open-Angle Glaucoma Therapeutics Industry
    1.6.1.1 Open-Angle Glaucoma Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Open-Angle Glaucoma Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Open-Angle Glaucoma Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Open-Angle Glaucoma Therapeutics Market Perspective (2015-2026)
2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Regions
  2.2.1 Open-Angle Glaucoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Open-Angle Glaucoma Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Open-Angle Glaucoma Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Open-Angle Glaucoma Therapeutics Players by Market Size
  3.1.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio
  3.2.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2019
3.3 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
3.5 Date of Enter into Open-Angle Glaucoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2021-2026)

5 OPEN-ANGLE GLAUCOMA THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
6.2 Open-Angle Glaucoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
7.2 Open-Angle Glaucoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
8.2 Open-Angle Glaucoma Therapeutics Key Players in China (2019-2020)
8.3 China Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
8.4 China Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
9.2 Open-Angle Glaucoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
10.2 Open-Angle Glaucoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
11.2 Open-Angle Glaucoma Therapeutics Key Players in India (2019-2020)
11.3 India Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
11.4 India Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Open-Angle Glaucoma Therapeutics Market Size (2015-2020)
12.2 Open-Angle Glaucoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Aerie Pharmaceuticals Inc.
  13.1.1 Aerie Pharmaceuticals Inc. Company Details
  13.1.2 Aerie Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction
  13.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020))
  13.1.5 Aerie Pharmaceuticals Inc. Recent Development
13.2 Allergan Plc
  13.2.1 Allergan Plc Company Details
  13.2.2 Allergan Plc Business Overview and Its Total Revenue
  13.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction
  13.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
  13.2.5 Allergan Plc Recent Development
13.3 Bausch Health Companies, Inc.
  13.3.1 Bausch Health Companies, Inc. Company Details
  13.3.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue
  13.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction
  13.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
  13.3.5 Bausch Health Companies, Inc. Recent Development
13.4 Novartis AG
  13.4.1 Novartis AG Company Details
  13.4.2 Novartis AG Business Overview and Its Total Revenue
  13.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction
  13.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
  13.4.5 Novartis AG Recent Development
13.5 Pfizer Inc.
  13.5.1 Pfizer Inc. Company Details
  13.5.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction
  13.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020)
  13.5.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Open-Angle Glaucoma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
Table 3. Ranking of Global Top Open-Angle Glaucoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Prostaglandin Analogs (PGAs)
Table 6. Key Players of Combination of PGAs
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Open-Angle Glaucoma Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Open-Angle Glaucoma Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Open-Angle Glaucoma Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Open-Angle Glaucoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Open-Angle Glaucoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Open-Angle Glaucoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Open-Angle Glaucoma Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Open-Angle Glaucoma Therapeutics Players
Table 24. Global Open-Angle Glaucoma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Open-Angle Glaucoma Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2019)
Table 27. Global Open-Angle Glaucoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
Table 30. Date of Enter into Open-Angle Glaucoma Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Open-Angle Glaucoma Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Open-Angle Glaucoma Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Open-Angle Glaucoma Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 40. North America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 42. North America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 46. Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 52. China Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 54. China Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 58. Japan Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 70. India Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 72. India Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Open-Angle Glaucoma Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Open-Angle Glaucoma Therapeutics Market Share (2019-2020)
Table 76. Central & South America Open-Angle Glaucoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Open-Angle Glaucoma Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Open-Angle Glaucoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Open-Angle Glaucoma Therapeutics Market Share by Application (2015-2020)
Table 80. Aerie Pharmaceuticals Inc. Company Details
Table 81. Aerie Pharmaceuticals Inc. Business Overview
Table 82. Aerie Pharmaceuticals Inc. Product
Table 83. Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 84. Aerie Pharmaceuticals Inc. Recent Development
Table 85. Allergan Plc Company Details
Table 86. Allergan Plc Business Overview
Table 87. Allergan Plc Product
Table 88. Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 89. Allergan Plc Recent Development
Table 90. Bausch Health Companies, Inc. Company Details
Table 91. Bausch Health Companies, Inc. Business Overview
Table 92. Bausch Health Companies, Inc. Product
Table 93. Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 94. Bausch Health Companies, Inc. Recent Development
Table 95. Novartis AG Company Details
Table 96. Novartis AG Business Overview
Table 97. Novartis AG Product
Table 98. Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 99. Novartis AG Recent Development
Table 100. Pfizer Inc. Company Details
Table 101. Pfizer Inc. Business Overview
Table 102. Pfizer Inc. Product
Table 103. Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2015-2020) (Million US$)
Table 104. Pfizer Inc. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Open-Angle Glaucoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Prostaglandin Analogs (PGAs) Features
Figure 3. Combination of PGAs Features
Figure 4. Other Features
Figure 5. Global Open-Angle Glaucoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Other Case Studies
Figure 10. Open-Angle Glaucoma Therapeutics Report Years Considered
Figure 11. Global Open-Angle Glaucoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Open-Angle Glaucoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Open-Angle Glaucoma Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Open-Angle Glaucoma Therapeutics Market Share by Players in 2019
Figure 16. Global Top Open-Angle Glaucoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Open-Angle Glaucoma Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Open-Angle Glaucoma Therapeutics Revenue in 2019
Figure 18. North America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Open-Angle Glaucoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Aerie Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Aerie Pharmaceuticals Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 27. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Plc Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 29. Bausch Health Companies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bausch Health Companies, Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 31. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis AG Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 33. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pfizer Inc. Revenue Growth Rate in Open-Angle Glaucoma Therapeutics Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed